DPF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.951400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.368800E-01
Normal-vs-Stage2
3.302000E-01
Normal-vs-Stage3
1.278400E-01
Normal-vs-Stage4
4.654200E-01
Stage1-vs-Stage2
3.719600E-01
Stage1-vs-Stage3
1.550790E-01
Stage1-vs-Stage4
7.885800E-01
Stage2-vs-Stage3
5.660200E-02
Stage2-vs-Stage4
9.484800E-01
Stage3-vs-Stage4
2.490200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.070000E-01
Normal-vs-AfricanAmerican
4.127400E-01
Normal-vs-Asian
2.386800E-01
Caucasian-vs-AfricanAmerican
7.753600E-01
Caucasian-vs-Asian
6.785400E-01
AfricanAmerican-vs-Asian
5.500000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.204400E-01
Normal-vs-Female
2.751000E-01
Male-vs-Female
9.694800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.656400E-01
Normal-vs-Age(41-60Yrs)
6.251200E-01
Normal-vs-Age(61-80Yrs)
2.044200E-01
Normal-vs-Age(81-100Yrs)
2.217400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.990600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.262200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.015800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.570110E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.279800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.633400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.559180E-01
Normal-vs-Daily Drinker
3.446600E-01
Normal-vs-Weekly Drinker
2.935800E-01
Normal-vs-Occasional Drinker
4.907600E-01
Normal-vs-Social Drinker
5.770400E-01
Non Drinker-vs-Daily Drinker
2.738000E-01
Non Drinker-vs-Weekly Drinker
5.724600E-01
Non Drinker-vs-Occasional Drinker
7.163800E-02
Non Drinker-vs-Social Drinker
9.403900E-02
Daily Drinker-vs-Weekly Drinker
7.170800E-01
Daily Drinker-vs-Occasional Drinker
4.699000E-01
Daily Drinker-vs-Social Drinker
4.819200E-01
Weekly Drinker-vs-Occasional Drinker
3.111800E-01
Weekly Drinker-vs-Social Drinker
3.437400E-01
Occasional Drinker-vs-Social Drinker
9.488800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.941400E-01
Normal-vs-Grade 2
7.090800E-01
Normal-vs-Grade 3
6.901000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.056230E-01
Grade 1-vs-Grade 3
7.837600E-02
Grade 1-vs-Grade 4
7.941400E-01
Grade 2-vs-Grade 3
6.130000E-01
Grade 2-vs-Grade 4
7.090800E-01
Grade 3-vs-Grade 4
6.901000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.444200E-01
Normal-vs-NonDiabetic
2.748800E-01
Diabetic-vs-NonDiabetic
2.230000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.647400E-01
Normal-vs-NoPancreatitis
2.083400E-01
Pancreatitis-vs-NoPancreatitis
1.235550E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.869000E-01
Normal-vs-N1
3.167200E-01
N0-vs-N1
9.728800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.894000E-01
Normal-vs-TP53-NonMutant
3.905800E-01
TP53-Mutant-vs-TP53-NonMutant
2.258100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
